OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement